Burkholderia thailandensis Is Virulent in Drosophila melanogaster

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Pilátová, Martina ^a   Dionne, Marc S ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

POLYPEPTIDE ANTIBIOTIC AGENT;

ARTICLE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; BURKHOLDERIA INFECTION; BURKHOLDERIA THAILANDENSIS; CONTROLLED STUDY; DROSOPHILA MELANOGASTER; HOST PATHOGEN INTERACTION; IMMUNE RESPONSE; INNATE IMMUNITY; MALE; NONHUMAN; PHAGOCYTE; PROTEIN EXPRESSION; SURVIVAL PREDICTION; SURVIVAL RATE; TEMPERATURE DEPENDENCE; TOXIN SYNTHESIS;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL SECRETION SYSTEMS; BURKHOLDERIA; CULTURE MEDIA, CONDITIONED; DROSOPHILA MELANOGASTER; HEMOCYTES; IMMUNITY, HUMORAL; MALE; TEMPERATURE; VIRULENCE;

ANIMALIA; BACTERIA (MICROORGANISMS); BURKHOLDERIA PSEUDOMALLEI; BURKHOLDERIA THAILANDENSIS; DROSOPHILA MELANOGASTER; INVERTEBRATA; NEGIBACTERIA;

EID: 84870266527     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049745     Document Type: Article

References (46)

1. Cheng AC, Currie BJ, (2005) Melioidosis: epidemiology, pathophysiology, and management. Clinical Microbiology Reviews 18: 383-416.
2. Smith MD, Wuthiekanun V, Walsh AL, White NJ, (1995) Quantitative recovery of Burkholderia pseudomallei from soil in Thailand. Transactions of the Royal Society of Tropical Medicine and Hygiene 89: 488-490.
3. Chaowagul W, White NJ, Dance DA, Wattanagoon Y, Naigowit P, et al. (1989) Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand. Journal of Infectious Diseases 159: 890-899.
4. White NJ, (2003) Melioidosis. Lancet 361: 1715-1722.
5. Currie BJ, Fisher DA, Howard DM, Burrow JN, Selvanayagam S, et al. (2000) The epidemiology of melioidosis in Australia and Papua New Guinea. Acta Tropica 74: 121-127.
6. Chaowagul W, Suputtamongkol Y, Dance DA, Rajchanuvong A, Pattara-arechachai J, et al. (1993) Relapse in melioidosis: incidence and risk factors. Journal of Infectious Diseases 168: 1181-1185.
7. Currie BJ, Fisher DA, Howard DM, Burrow JN, Lo D, et al. (2000) Endemic melioidosis in tropical northern Australia: a 10-year prospective study and review of the literature. Clinical Infectious Diseases 31: 981-986.
8. Suputtamongkol Y, Chaowagul W, Chetchotisakd P, Lertpatanasuwun N, Intaranongpai S, et al. (1999) Risk factors for melioidosis and bacteremic melioidosis. Clinical Infectious Diseases 29: 408-413.
9. Brett PJ, DeShazer D, Woods DE, (1997) Characterization of Burkholderia pseudomallei and Burkholderia pseudomallei-like strains. Epidemiology and Infection 118: 137-148.
10. Pilatz S, Breitbach K, Hein N, Fehlhaber B, Schulze J, et al. (2006) Identification of Burkholderia pseudomallei genes required for the intracellular life cycle and in vivo virulence. Infection and Immunity 74: 3576-3586.
11. Stevens JM, Ulrich RL, Taylor LA, Wood MW, DeShazer D, et al. (2005) Actin-binding proteins from Burkholderia mallei and Burkholderia thailandensis can functionally compensate for the actin-based motility defect of a Burkholderia pseudomallei bimA mutant. Journal of Bacteriology 187: 7857-7862.
12. Rotz LD, Khan AS, Lillibridge SR, Ostroff SM, Hughes JM, (2002) Public health assessment of potential biological terrorism agents. Emerging Infectious Diseases 8: 225-230.
13. Schweizer HP, Peacock SJ, (2008) Antimicrobial Drug-Selection Markers for Burkholderia pseudomallei and B. mallei. Emerging Infectious Diseases 14: 1689-1692.
14. Vorachit M, Lam K, Jayanetra P, Costerton JW, (1993) Resistance of Pseudomonas pseudomallei growing as a biofilm on silastic discs to ceftazidime and co-trimoxazole. Antimicrobial Agents and Chemotherapy 37: 2000-2002.
15. Brett PJ, DeShazer D, Woods DE, (1998) Burkholderia thailandensis sp. nov., a Burkholderia pseudomallei-like species. International Journal of Systematic Bacteriology 48: 317-320.
16. Kim HS, Schell MA, Yu Y, Ulrich RL, Sarria SH, et al. (2005) Bacterial genome adaptation to niches: divergence of the potential virulence genes in three Burkholderia species of different survival strategies. BMC Genomics 6: 174.
17. Yu Y, Kim HS, Chua HH, Lin CH, Sim SH, et al. (2006) Genomic patterns of pathogen evolution revealed by comparison of Burkholderia pseudomallei, the causative agent of melioidosis, to avirulent Burkholderia thailandensis. BMC Microbiology 6: 46.
18. Haraga A, West TE, Brittnacher MJ, Skerrett SJ, Miller SI, (2008) Burkholderia thailandensis as a model system for the study of the virulence-associated type III secretion system of Burkholderia pseudomallei. Infection and Immunity 76: 5402-5411.
19. Wiersinga WJ, de Vos AF, de Beer R, Wieland CW, Roelofs JJTH, et al. (2008) Inflammation patterns induced by different Burkholderia species in mice. Cellular Microbiology 10: 81-87.
20. Kespichayawattana W, Rattanachetkul S, Wanun T, Utaisincharoen P, Sirisinha S, (2000) Burkholderia pseudomallei Induces Cell Fusion and Actin-Associated Membrane Protrusion: a Possible Mechanism for Cell-to-Cell Spreading. Infection and Immunity 68: 5377-5384.
21. Stevens MP, Stevens JM, Jeng RL, Taylor LA, Wood MW, et al. (2005) Identification of a bacterial factor required for actin-based motility of Burkholderia pseudomallei. Molecular Microbiology 56: 40-53.
22. Lertpatanasuwan N, Sermsri K, Petkaseam A, Trakulsomboon S, Thamlikitkul V, et al. (1999) Arabinose-positive Burkholderia pseudomallei infection in humans: case report. Clinical Infectious Diseases 28: 927-928.
23. Glass MB, Gee JE, Steigerwalt AG, Cavuoti D, Barton T, et al. (2006) Pneumonia and septicemia caused by Burkholderia thailandensis in the United States. Journal of Clinical Microbiology 44: 4601-4604.
24. Dionne MS, Ghori N, Schneider DS, (2003) Drosophila melanogaster is a genetically tractable model host for Mycobacterium marinum. Infection and Immunity 71: 3540-3550.
25. Brandt SM, Dionne MS, Khush RS, Pham LN, Vigdal TJ, et al. (2004) Secreted Bacterial Effectors and Host-Produced Eiger/TNF Drive Death in a Salmonella-Infected Fruit Fly. PLoS Biology 2: e418.
26. Needham AJ, Kibart M, Crossley H, Ingham PW, Foster SJ, (2004) Drosophila melanogaster as a model host for Staphylococcus aureus infection. Microbiology 150: 2347-2355.
27. Castonguay-Vanier J, Vial L, Tremblay J, Déziel E, (2010) Drosophila melanogaster as a model host for the Burkholderia cepacia complex. PLoS ONE 5: e11467.
28. Schneider DS, Ayres JS, Brandt SM, Costa A, Dionne MS, et al. (2007) Drosophila eiger mutants are sensitive to extracellular pathogens. PLoS Pathogens 3: e41.
29. Schwarz S, West TE, Boyer F, Chiang WC, Carl MA, et al. (2010) Burkholderia type VI secretion systems have distinct roles in eukaryotic and bacterial cell interactions. PLoS Pathogens 6: e1001068.
30. Sarkar-Tyson M, Smither SJ, Harding SV, Atkins TP, Titball RW, (2009) Protective efficacy of heat-inactivated B. thailandensis, B. mallei or B. pseudomallei against experimental melioidosis and glanders. Vaccine 27: 4447-4451.
31. Cho Y, Griswold A, Campbell C, Min K-T, (2005) Individual histone deacetylases in Drosophila modulate transcription of distinct genes. Genomics 86: 606-617.
32. Ranz JM, Casals F, Ruiz A, (2001) How malleable is the eukaryotic genome? Extreme rate of chromosomal rearrangement in the genus Drosophila. Genome Research 11: 230-239.
33. Apidianakis Y, Rahme LG, (2009) Drosophila melanogaster as a model host for studying Pseudomonas aeruginosa infection. Nature protocols 4: 1285-1294.
34. Haase A, Janzen J, Barrett S, Currie B, (1997) Toxin production by Burkholderia pseudomallei strains and correlation with severity of melioidosis. Journal of Medical Microbiology 46: 557-563.
35. Häussler S, Nimtz M, Domke T, Wray V, Steinmetz I, (1998) Purification and characterization of a cytotoxic exolipid of Burkholderia pseudomallei. Infection and Immunity 66: 1588-1593.
36. Hedengren M, Åsling B, Dushay MS, Ando I, Ekengren S, et al. (1999) Relish, a central factor in the control of humoral but not cellular immunity in Drosophila. Molecular Cell 4: 827-837.
37. Rutschmann S, Jung AC, Hetru C, Reichhart JM, Hoffmann JA, et al. (2000) The Rel Protein DIF Mediates the Antifungal but Not the Antibacterial Host Defense in Drosophila. Immunity 12: 569-580.
38. Avet-Rochex A, Bergeret E, Attree I, Meister M, Fauvarque M-O, (2005) Suppression of Drosophila cellular immunity by directed expression of the ExoS toxin GAP domain of Pseudomonas aeruginosa. Cellular Microbiology 7: 799-810.
39. Chamilos G, Lewis RE, Hu J, Xiao L, Zal T, et al. (2008) Drosophila melanogaster as a model host to dissect the immunopathogenesis of zygomycosis. PNAS 105: 9367-9372.
40. Limmer S, Haller S, Drenkard E, Lee J, Yu S, et al. (2011) Pseudomonas aeruginosa RhlR is required to neutralize the cellular immune response in a Drosophila melanogaster oral infection model. PNAS 108: 17378-17383.
41. Mansfield BE, Dionne MS, Schneider DS, Freitag NE, (2003) Exploration of host-pathogen interactions using Listeria monocytogenes and Drosophila melanogaster. Cellular Microbiology 5: 901-911.
42. D'Argenio DA, Gallagher LA, Berg CA, Manoil C, (2001) Drosophila as a model host for Pseudomonas aeruginosa infection. Journal of Bacteriology 183: 1466-1471.
43. Jones AL, Beveridge TJ, Woods DE, (1996) Intracellular survival of Burkholderia pseudomallei. Infection and Immunity 64: 782-790.
44. Mallard F, Antony C, Tenza D, Salamero J, Goud B, et al. (1998) Direct pathway from early/recycling endosomes to the Golgi apparatus revealed through the study of shiga toxin B-fragment transport. The Journal of cell biology 143: 973-990.
45. van Deurs B, Petersen OW, Olsnes S, Sandvig K, (1987) Delivery of internalized ricin from endosomes to cisternal Golgi elements is a discontinuous, temperature-sensitive process. Experimental Cell Research 171: 137-152.
46. Kikuchi Y, Hayatsu M, Hosokawa T, Nagayama A, Tago K, et al. (2012) Symbiont-mediated insecticide resistance. PNAS 109: 8618-8622.